About Careers MedBlog Contact us

Non-invasive Brain Imaging Method to Detect Alzheimer's Disease

by Julia Samuel on December 29, 2014 at 5:32 PM
Font : A-A+

Non-invasive Brain Imaging Method to Detect Alzheimer's Disease

Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and gets worse over time and accounts for 60% to 70% of cases of dementia.

The scientists and engineers in Northwestern University have developed a non-invasive MRI (magnetic resonance imaging) probe. The technique pairs a magnetic nanostructure (MNS) with an antibody that seeks out the amyloid beta brain toxins responsible for onset of Alzheimer's disease.


The accumulated toxins have associated magnetic nanostructures and they help show up as dark areas in MRI scans of the brain.

"We have a new brain imaging method that can detect the toxin that leads to Alzheimer's disease," said neuroscientist William L Klein who led the research team along with materials scientist Vinayak P Dravid.

"Using MRI, we can see the toxins attached to neurons in the brain. We expect to use this tool to detect this disease early and to help identify drugs that can effectively eliminate the toxin and improve health," Klein said.

The conventional imaging method is by positron emission tomography using probes that target amyloid fibrils but these fibrils are not closely linked to the development of the disease, said the study.

The new technology is detecting something different from conventional technology: toxic amyloid beta oligomers instead of plaques, which occur at a stage of Alzheimer's when it is useless to give therapeutic intervention. It is believed that Amyloid beta oligomers is the the culprit in the onset of Alzheimer's disease and subsequent memory loss.

In a person suffering from Alzheimer's, the mobile amyloid beta oligomers attack the synapses of neurons, destroying memory and ultimately resulting in neuron death.

"Non-invasive imaging by MRI of amyloid beta oligomers is a giant step forward towards diagnosis of this debilitating disease in its earliest form," said Dravid, the Abraham Harris Professor of Materials Science and Engineering at the McCormick School of Engineering and Applied Science.

"This MRI method could be used to determine how well a new drug is working. If a drug is effective, you would expect the amyloid beta signal to go down," Dravid said.

Source: Medindia


Recommended Reading

Latest Research News

Omega-3 Can Save Alzheimer's Patients from Vision Loss
Does omega-3 help Alzheimer's patients? A new form of omega-3 helped restore specific markers of eye health in mice bred with aspects of early-onset Alzheimer's disease.
Why Is Asthma Linked to Increased Risk of Osteoarthritis?
Drugs used to inhibit the physiological responses for allergic reactions lessen osteoarthritis risk, revealed research.
 Experiments on Child Brain Tumour and Muscle Ageing Heading to Space
The International Space Station will be used to carry out experiments seeking to improve understanding of incurable child brain tumors and the muscle aging process.
 Nearly 1 In 5 UK Adults Experience Negative Responses to Sounds
How many people in the UK have misophonia? In a representative sample study, most people had at least some irritation upon hearing trigger sounds.
Why Are 1 in 8 Indians at Risk of Irreversible Blindness
Routine eye-checkups and mass screenings enable early diagnosis and treatment of glaucoma. Late-stage glaucoma diagnosis leads to blindness.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Non-invasive Brain Imaging Method to Detect Alzheimer's Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests